We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Silencing Protein Found to Be Enzyme Modifier

By Biotechdaily staff writers
Posted on 24 Jan 2003
Researchers have found that the Sir2 protein, known to be required for gene silencing, modifies the enzyme acetyl-CoA synthetase that may be related to the extended lifespan in many organisms resulting when calories are restricted. More...
The finding was reported in the December 20, 2002, issue of Science.

Silencing is a form of transcriptional repression that renders large chromatin domains inaccessible to the transcription machinery. Silenced domains are refractile to recombination, replicate late in S phase and are inaccessible to some but not all molecular probes. In Saccharomyces cerevisiae (budding yeast) silencing occurs at three loci: the cryptic mating type loci, HMR and HML; the telomeres (referred as telomeric position effect, TPE); and at the rDNA locus (called RPE).

SIR2 distinguishes itself from the other SIR genes as it is essential for the three types of silencing and is conserved from bacteria to man. Four paralogs of Sir2p exist in budding yeast, the Hst1-4 proteins, and more than one Sir2 ortholog is found in all other species examined. They are called sirtuins. Recently, numerous studies have demonstrated that Sir2p is an in vitro NAD-dependent deacetylase and that this enzymatic activity appears to correlate with repression at the HM, telomeres, and rDNA loci. However, the physiologic Sir2p substrates have not yet been identified.

Working with a mutated strain of bacteria lacking sirtuins, investigators from Johns Hopkins University (Baltimore, MD, USA; www.jhu.edu) and the University of Wisconsin (Madison, USA; www.wisc.edu) discovered that Sir2 was a crucial modifier of the enzyme acetyl-CoA synthetase, which converts acetate into acetyl-CoA in a two-step process. Acetyl-CoA then can directly fuel the citric acid cycle, the central energy-producing step in cellular respiration.

"This is a completely new target for the sirtuin protein,” explained investigator Dr. Jeff Boeke, professor of molecular biology and genetics at Johns Hopkins' Institute for Basic Biomedical Sciences. "Converting acetate is not the cell's only way of making acetyl-CoA, but when acetate is the major energy source, it is crucial. Now we have to check for this role in other organisms.”




Related Links:
John Hopkins University
University of Wisconsin

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.